drugset / Trial / NCT00501579

Study of Difluprednate in the Treatment of Uveitis

NCT00501579

Phase 3 Completed Sirion Therapeutics, Inc.
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Difluprednate Small molecule 0.05 % Topical
Subject Prednisolone Other / unclassified 1 % Topical

Indications